US Patent 10040751 Intermediates for macrocyclic compounds
Patent 10040751 was granted and assigned to Ocera Therapeutics on August, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+161 characters)
Article
Patent abstract
The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates:
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Carl St-Louis0
Eric Marsault0
Hamid Hoveyda0
Kamel Benakli0
Luc Ouellet0
Mark L. Peterson0
Sophie Beauchemin0
Sylvie Beaubien0
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10040751 Intermediates for macrocyclic compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10040751
Date of patent
August 7, 2018
Patent application number
14873056
Date Filed
October 1, 2015
Patent primary examiner
Find more entities like US Patent 10040751 Intermediates for macrocyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.